References for:
Adulteration of Dietary Supplements

[Am J Health-Syst Pharm 60(15):1576-1580, 2003. © 2003 American Society of Health-System Pharmacists]

  1. McNamara SH, Siegner AW Jr, Phelps EP. DSHEA provisions confine FDA's authority to issue regulations that concern allegedly adulterated dietary supplements. Food Drug Law J. 1999; 54:595-8.
  2. Miller LG, Hume A, Harris IM et al. Adulteration: its various meanings. Pharmacotherapy. 2001; 21:770-1.
  3. Barlow-Pugh M, ed. Stedman's medical dictionary. 27th ed. Baltimore: Lippincott, Williams, and Wilkins; 2000:30,404.
  4. Petty HR, Fernando M, Kindzelskii AL et al. Identification of colchicine in placental blood from patients using herbal medicines. Chem Res Toxicol. 2001; 14: 1254-8.
  5. Slifman NR, Obermeyer WR, Aloi BK et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med. 1998; 339:806-11.
  6. Van Hulle M, Zhang C, Zhang X et al. Arsenic speciation in Chinese seaweeds using HPLC-ICP-MS and HPLC-ES-MS. Analyst. 2002; 127:634-40.
  7. Van Netten C, Hoption Cann SA, Morley DR et al. Elemental and radioactive analysis of commercially available seaweed. Sci Total Environ. 2000; 255:169-75.
  8. Pye KG, Kelsey SM, House IM et al. Severe dyserythropoiesis and autoimmune thrombocytopenia associated with ingestion of kelp supplements. Lancet. 1992; 339:1540. Letter.
  9. Tornheim K, Lowenstein JM. Creatine phosphate inhibition of heart lactate dehydrogenase and muscle pyruvate kinase is due to a contaminant. J Biol Chem. 1979; 254:10586-7.
  10. Tait PA, Vora A, James S et al. Severe congenital lead poisoning in a preterm infant due to a herbal remedy. Med J Aust. 2002; 177:193-5.
  11. Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol. 2002; 57:891-6.
  12. Food and Drug Administration. Pacific Biologic recalls seven products that contain the herb Akebia trifoliata caulis (mu tong) and the herb Asarum sieboldii herba cum radix (xin xin) because of a possible health risk. (accessed 2003 Apr 23).
  13. Krone CA, Wyse EJ, Ely JT. Cadmium in zinc-containing mineral supplements. Int J Food Sci Nutr. 2001; 52:379-82.
  14. Food and Drug Administration. Vita Nutrients recalls Joint Ease and Verified Quality Brand Joint Comfort Complex because of adverse health risk associated with aristolochic acid. (accessed 2003 Apr 23).
  15. Johanns ES, van der Kolk LE, van Gemert HM et al. [An epidemic of epileptic seizures after consumption of herbal tea.] Ned Tijdschr Geneeskd. 2002; 146:813-6. In Dutch.
  16. Rhoads PM, Tong TG, Banner W Jr et al. Anticholinergic poisonings associated with commercial burdock root tea. J Toxicol Clin Toxicol. 1984-85; 22:581-4.
  17. Bryson PD, Watanabe AS, Rumack BH et al. Burdock root tea poisoning. Case report involving a commercial preparation. JAMA. 1978; 239:2157.
  18. Parsons JS. Contaminated herbal tea as a potential source of chronic arsenic poisoning. N C Med J. 1981; 42:38-9.
  19. Huggett DB, Khan IA, Allgood JC et al. Organochlorine pesticides and metals in select botanical dietary supplements. Bull Environ Contam Toxicol. 2001; 66:150-5.
  20. Gilroy DJ, Kauffman KW, Hall RA et al. Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements. Environ Health Perspect. 2000; 108:435-9.
  21. Ross EA, Szabo NJ, Tebbett IR. Lead content of calcium supplements. JAMA. 2000; 284:1425-9.
  22. Bourgoin BP, Evans DR, Cornett JR et al. Lead content in 70 brands of dietary calcium supplements. Am J Public Health. 1993; 83:1155-60.
  23. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol. 2000; 143: 923-9.
  24. Klarskov K, Johnson KL, Benson LM et al. Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan. Adv Exp Med Biol. 1999; 467:461-8.
  25. Eidson M, Philen RM, Sewell CM et al. L-tryptophan and eosinophilia-myalgia syndrome in New Mexico. Lancet. 1990; 335:645-8.
  26. Vanherweghem LJ. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med. 1998; 4(1):9-13.
  27. Jacobs MN, Santillo D, Johnston PA et al. Organochlorine residues in fish oil supplements: comparison with industrial grade oils. Chemosphere. 1998; 37:1709-21.
  28. Jimenez B, Wright C, Kelly M et al. Levels of PCDDs, PCDFs and non-ortho PCBs in dietary supplement fish oil obtained in Spain. Chemosphere. 1996; 32:461-7.
  29. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998; 339:847. Letter.
  30. Adult lead poisoning from an Asian remedy for menstrual cramps -- Connecticut, 1997. MMWR Morb Mortal Wkly Rep. 1999; 48:27-9.
  31. Williamson BL, Tomlinson AJ, Mishra PK et al. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated eosinophiliamyalgia syndrome. Chem Res Toxicol. 1998; 11:234-40.
  32. Crosby WH. Lead-contaminated health food. Association with lead poisoning and leukemia. JAMA. 1977; 237:2627-9.
  33. Wu MS, Hong JJ, Lin JL et al. Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium. Nephrol Dial Transplant. 1996; 11:867-70.
  34. De Smet PA, Smeets OS. Potential risks of health food products containing yohimbe extracts. BMJ. 1994; 309:958. Letter.
  35. Lewis C. Dietary supplement maker fined twice what company profited. FDA Consum. 2001; 35(1):34-5.
  36. Ries CA, Sahud MA. Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone. JAMA. 1975; 231:352-5.
  37. Wooltorton E. Hua fo tablets tainted with sildenafil-like compound. CMAJ. 2002; 166:1568.
  38. Segasothy M, Samad S. Illicit herbal preparation containing phenylbutazone causing analgesic nephropathy. Nephron. 1991; 59:166-7. Letter.
  39. Capobianco DJ, Brazis PW, Fox TP. Proximal-muscle weakness induced by herbs. N Engl J Med. 1993; 329:1430. Letter.
  40. Lau KK, Lai CK, Chan AW. Phenytoin poisoning after using Chinese proprietary medicines. Hum Exp Toxicol. 2000; 19: 385-6.
  41. Goudie AM, Kaye JM. Contaminated medication precipitating hypoglycaemia. Med J Aust. 2001; 175:256-7.
  42. Abt AB, Oh JY, Huntington RA et al. Chinese herbal medicine induced acute renal failure. Arch Intern Med. 1995; 155: 211-2.
  43. Ros JJ, Pelders MG, De Smet PA. A case of positive doping associated with a botanical food supplement. Pharm World Sci. 1999; 21:44-6.
  44. Sovak M, Seligson AL, Konas M et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst. 2002; 94:1275-81.
  45. Evans WC, Evans D, eds. Trease & Evans' pharmacognosy. 15th ed. Philadelphia: W. B. Saunders; 2002:55-94.
  46. Norton SA. Raw animal tissues and dietary supplements. N Engl J Med. 2000; 343:304-5. Letter.
  47. U.S. Department of Agriculture. Detention without physical examination of bulk shipments of high-risk tissue from BSE-countries -- bovine spongiform encephalopathy. Import alert #17-04. _import _ ia1704.html (accessed 2003 Apr 23).
  48. Heaney RP. Lead in calcium supplements: cause for alarm or celebration? JAMA. 2000; 284:1432-3. Editorial.
  49. Malawska M, Wilkomirski B. Accumulation rate of polychlorinated biphenyls (PCBs) in dandelion (Taraxacum officinale) in the conditions of soil contamination with oil derivatives. Rocz Panstw Zakl Hig. 2001; 52:295-311.
  50. D'Arcy PF. Adverse reactions and interactions with herbal medicines. Part 1. Adverse reactions. Adverse Drug React Toxicol Rev. 1991; 10:189-208.
  51. Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998; 104: 170-8.
  52. Bartels CL, Miller SJ. Herbal and related remedies. Nutr Clin Pract. 1998; 12:5-19.
  53. Zamula E. Of pills that pack too much punch. FDA Consum. 1984; 18(Feb):38-40.
  54. Center for Drug Evaluation and Research. 21 C.F.R. Parts 210 and 211. (accessed 2003 Apr 23).
  55. Office of Inspector General. Adverse event reporting for dietary supplements: an inadequate safety valve. OEI-01-00-00180. (accessed 2003 Apr 23).
  56. Cohen MH, Eisneberg DM. Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med. 2002; 136:596-603.